L-2-hydroxyglutaric aciduria (L-2-HGA) is a rare inherited metabolic disorder characterized by abnormal amino acid metabolism, in particular, accumulation of L-2-hydroxyglutaric acid in the body. The disease is caused by a deficiency of a specific enzyme involved in the glutamate metabolism cycle, which leads to excess of this acid in the serum and urine. Clinical manifestations can vary from mild symptoms to severe neurological impairment, including psychomotor retardation, seizures, and ataxia. The condition is often diagnosed in childhood, but sometimes manifests itself later.
History of the disease and interesting historical facts
L-2-hydroxyglutaric aciduria was first described in the medical literature in the late 20th century, when scientists identified specific metabolic abnormalities in patients with corresponding clinical symptoms. Initially, the disease went unnoticed due to its rarity and similarity to other metabolic disorders. In 1995, researchers first identified the disorder as a separate nosology, which opened up new horizons for diagnosis and treatment. Scientific research conducted since then has led to a better understanding of the pathogenesis of the disease, as well as to the development of methods for its diagnosis and monitoring.
Epidemiology
According to various data, L-2-hydroxyglutaric aciduria occurs with a frequency of 1 in 5-10 thousand newborns. However, due to low awareness among health workers and a wide range of clinical manifestations, many cases remain undiagnosed. In some ethnic groups or families where cases of this pathology are observed, the frequency increases, which may indicate a hereditary nature of the disease.
Genetic predisposition to this disease
L-2-hydroxyglutaric aciduria is an autosomal recessive disorder caused by mutations in the IDH2 (isocitrate dehydrogenase 2) gene. This gene codes for the enzyme needed to convert isocitrate to alpha-ketoglutarate. The main mutations associated with this disorder are dots and small deletions. It is important to note that both parents must be carriers of the mutation for the offspring to develop the disorder.
Risk factors for the development of this disease
Risk factors for the development of L-2-hydroxyglutaric aciduria include:
- Heredity. The presence of cases of the disease in the family increases the likelihood of its development in offspring.
- Ethnicity: In some populations, such as Jewish populations, the incidence may be higher due to a narrower genetic pool.
- Environmental factors: Links have been shown between the development of metabolic disorders and exposure to certain chemicals, but in the case of L-2-GA this issue requires further research.
Diagnosis of this disease
For the diagnosis of L-2-hydroxyglutaric aciduria, a careful assessment of the clinical picture and the use of various laboratory and instrumental diagnostic methods are important.
The main symptoms of the disease include:
- Psychomotor retardation
- Seizures
- Changes in muscle tone
- Ataxia
Laboratory testing includes urine analysis for L-2-hydroxyglutaric acid, which can determine the presence of aciduria. Radiologic testing may include magnetic resonance imaging (MRI) to detect typical changes in the brain, such as acid accumulation and signs of demyelination. Differential diagnosis includes other inherited metabolic disorders, such as homocystinuria or methylmalonic aciduria.
Treatment
Treatment of L-2-hydroxyglutaric aciduria is primarily aimed at eliminating symptoms and correcting metabolic disorders.
General treatment includes:
- Following a low protein diet to reduce the production of toxic metabolites.
- Supportive therapy to prevent complications from the central nervous system.
Pharmacological treatment may include the use of specific supplements such as vitamin B6, which may have a positive effect on the clinical manifestations of the disease. Surgery may be necessary in cases where structural changes in the brain or other complications are observed. Overall, treatment remains individualized and depends on the severity of the patient's condition.
List of medications used to treat this disease
- Vitamin B6 (pyridoxine)
- Cartinic acids
- Anticonvulsants (if epileptic seizures are present)
- Supportive drugs (depending on clinical manifestations)
Disease monitoring
Monitoring the condition of patients with L-2-hydroxyglutaric aciduria includes regular control stages that allow tracking the dynamics of the disease and adjusting treatment:
- Laboratory tests to assess the level of L-2-hydroxyglutaric acid in urine and blood.
- Clinical assessments to determine the effectiveness of therapy and the presence of side effects.
- The prognosis depends on timely diagnosis and initiation of treatment; with adequate therapy, the prognosis can be relatively favorable, although complications such as mental retardation or neurological disorders are possible.
Age-related features of the disease
The symptoms and course of the disease may vary depending on the age group. In neonates and infants, L-2-hydroxyglutaric aciduria may present with acute neurological deficits and developmental delays, while in older children and adults, the disorder may present with less severe symptoms or remain undiagnosed for many years.
Questions and Answers
- What causes L-2-hydroxyglutaric aciduria? The disease occurs due to mutations in the IDH2 gene, which leads to a deficiency of an enzyme involved in amino acid metabolism.
- How to diagnose L-2-hydroxyglutaric aciduria? Diagnosis is based on laboratory analysis of urine for L-2-hydroxyglutaric acid and clinical symptoms.
- What treatment is needed for this disease? Treatment includes a low-protein diet, B vitamins, and anticonvulsants if needed.
- What is the prognosis for L-2-hydroxyglutaric aciduria? The prognosis may be favorable if the treatment regimen is followed, but complications may develop, including neurological disorders.
- How often should I have check-ups? Regular check-ups to monitor acid levels are recommended at least every 6 months.
Advice from Dr. Oleg Korzhikov
With L-2-hydroxyglutaric aciduria, it is important to pay attention to proper nutrition, which allows you to minimize the amount of toxic metabolites in the body. I recommend:
- Eating a diet rich in carbohydrates and low in protein helps reduce the production of L-2-hydroxyglutaric acid.
- Have regular medical checkups to assess your acid levels and overall health.
- It is important to consult with geneticists and metabolic specialists to optimize treatment and improve quality of life.
Take care of your health and monitor your condition, especially if you have a hereditary predisposition.
